Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment With Pemetrexed + Cisplatin for Advanced Non-squamous Non-Small Cell Lung Cancer.
Pemetrexed
H3E-EW-S124
NCT00789373
Nonsquamous Non-Small Cell Lung Cancer (NSCLC).
Phase 3
 
June 2015

Powered by ideaPoint, Inc.